. 2017 Jul;2().
doi: 10.1038/npjbcancer.2016.19.

Learning from big data: are we undertreating older women with high-risk breast cancer?

Joseph A Sparano 1 Hyman Muss 2 
  • PMID: 28721380
  •     26 References
  •     1 citations

No abstract available

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), R Peto, +15 authors, K Pritchard.
Lancet, 2011 Dec 14; 379(9814). PMID: 22152853    Free PMC article.
Highly Cited.
FDA's Foray Into Big Data Still Maturing.
Bridget M Kuehn.
JAMA, 2016 Apr 21; 315(18). PMID: 27097048
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.
Amye J Tevaarwerk, Robert J Gray, +7 authors, Joseph A Sparano.
Cancer, 2012 Oct 16; 119(6). PMID: 23065954    Free PMC article.
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007).
William B Wong, Scott D Ramsey, +2 authors, David L Veenstra.
Contemp Clin Trials, 2012 Sep 18; 33(6). PMID: 22981891    Free PMC article.
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.
Laurel A Habel, Steven Shak, +12 authors, Charles P Quesenberry.
Breast Cancer Res, 2006 Jun 02; 8(3). PMID: 16737553    Free PMC article.
Highly Cited.
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.
Hyman B Muss, Susan Woolf, +11 authors, Cancer and Leukemia Group B.
JAMA, 2005 Mar 03; 293(9). PMID: 15741529
Building a Rapid Learning Health Care System for Oncology: Why CancerLinQ Collects Identifiable Health Information to Achieve Its Vision.
Alaap Shah, Andrew K Stewart, +2 authors, Robert Miller.
J Clin Oncol, 2016 Jan 13; 34(7). PMID: 26755519
Development of the 21-gene assay and its application in clinical practice and clinical trials.
Joseph A Sparano, Soonmyung Paik.
J Clin Oncol, 2008 Feb 09; 26(5). PMID: 18258979
Highly Cited. Review.
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.
Kathy S Albain, William E Barlow, +18 authors, Breast Cancer Intergroup of North America.
Lancet, 2009 Dec 17; 374(9707). PMID: 20004966    Free PMC article.
Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer.
Joseph A Sparano, Fengmin Zhao, +7 authors, Nancy E Davidson.
J Clin Oncol, 2015 Jun 17; 33(21). PMID: 26077235    Free PMC article.
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
Dennis C Sgroi, Ivana Sestak, +9 authors, Mitch Dowsett.
Lancet Oncol, 2013 Sep 17; 14(11). PMID: 24035531    Free PMC article.
Highly Cited.
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Hyman B Muss, Donald A Berry, +7 authors, Cancer and Leukemia Group B Experience.
J Clin Oncol, 2007 Aug 21; 25(24). PMID: 17704418
Artificial Intelligence, Big Data, and Cancer.
Hagop Kantarjian, Peter Paul Yu.
JAMA Oncol, 2015 Jul 17; 1(5). PMID: 26181906
Future of cancer incidence in the United States: burdens upon an aging, changing nation.
Benjamin D Smith, Grace L Smith, +2 authors, Thomas A Buchholz.
J Clin Oncol, 2009 May 01; 27(17). PMID: 19403886
Highly Cited.
Breast Cancer in Women Older Than 80 Years.
Shlomit Strulov Shachar, Arti Hurria, Hyman B Muss.
J Oncol Pract, 2016 Feb 13; 12(2). PMID: 26869650
Improvement in breast cancer outcomes over time: are older women missing out?
Benjamin D Smith, Jing Jiang, +4 authors, Thomas A Buchholz.
J Clin Oncol, 2011 Nov 10; 29(35). PMID: 22067407
Adjuvant treatment of elderly breast cancer patients.
H B Muss.
Breast, 2007 Aug 31; 16 Suppl 2. PMID: 17728133
Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal.
CA Cancer J Clin, 2016 Jan 09; 66(1). PMID: 26742998
Highly Cited.
Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies.
Hyunsoon Cho, Carrie N Klabunde, +4 authors, Angela B Mariotto.
Ann Intern Med, 2013 Nov 20; 159(10). PMID: 24247672
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.
Marco Colleoni, Zhuoxin Sun, +8 authors, Aron Goldhirsch.
J Clin Oncol, 2016 Jan 21; 34(9). PMID: 26786933    Free PMC article.
Highly Cited.
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
Lori J Goldstein, Robert Gray, +12 authors, Joseph A Sparano.
J Clin Oncol, 2008 Aug 06; 26(25). PMID: 18678838    Free PMC article.
Highly Cited.
Annual hazard rates of recurrence for breast cancer after primary therapy.
T Saphner, D C Tormey, R Gray.
J Clin Oncol, 1996 Oct 01; 14(10). PMID: 8874335
Highly Cited.
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology.
Hans Wildiers, Ian Kunkler, +13 authors, Matti Aapro.
Lancet Oncol, 2007 Dec 07; 8(12). PMID: 18054880
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +28 authors, George W Sledge.
N Engl J Med, 2015 Sep 29; 373(21). PMID: 26412349    Free PMC article.
Highly Cited.
Decision theory for precision therapy of breast cancer.
Michael Kenn, Dan Cacsire Castillo-Tong, +4 authors, Wolfgang Schreiner.
Sci Rep, 2021 Feb 21; 11(1). PMID: 33608588